Abstract
Women in the UK have a 15% lifetime risk of developing breast cancer. Like other high‐income countries, women in the UK are having children later in life which increases their risk. The risk of breast cancer is reduced by 4.3% for every 12 months of breastfeeding, this is in addition to the 7.0% decrease in risk observed for each birth. Breastfeeding reduces the risk of Triple‐Negative Breast Cancer (20%) and in carriers of BRCA1 mutations (22–55%). The mechanisms of reduced risk as a result of pregnancy are related to changes in RNA processing and cellular differentiation. The UK has a low rate of breastfeeding (81%) and this is contrasted to countries with higher (Sweden, Australia) and lower rates (Ireland). The low UK rate is in part due to a lack of experience in the population, todays grandmothers have less experience with breastfeeding (62%) than their daughters. An estimated 4.7% of breast cancer cases in the UK are caused by not breastfeeding. The UK only has 43% of maternity services with full Baby‐Friendly accreditation which promotes compliance with the WHO ‘Ten Steps to Successful Breast Feeding’. Legislation in the UK and Europe is far short of the WHO Guidance on restricting the advertising of formula milk. Expansion of the Baby‐Friendly Hospital Initiative, stricter laws on the advertising of formula milk and legislation to support nursing mothers in the workplace have the potential to increase breastfeeding in the UK. Women with a family history of breast cancer should particularly be supported to breastfeed as a way of reducing their risk.
Keywords: BRCA1/2 mutation, breast cancer, breastfeeding, pregnancy, risk, triple‐negative breast cancer
1. INTRODUCTION
Breastfeeding has enormous benefits for both the mother and child. Babies who are breastfed have a reduced risk of death from infectious diseases, 1 hospitalisation for diarrhoea, 2 and fewer respiratory 2 and ear infections. 3 Children who were breastfed may have a reduced risk of asthma and allergic rhinitis but the evidence for this is not as strong. 4 Children and adults who were breastfed have a reduced risk of obesity and type 2 diabetes. 5 Mothers who breastfeed have a reduced long‐term risk of cardiovascular disease, 6 , 7 diabetes, 8 , 9 breast 10 , 11 and ovarian cancer. 10 The longer the duration of breastfeeding the greater the reduction in risk of disease. 7 , 8 , 9 , 10
2. WOMEN IN THE UK HAVE RELATIVELY SMALL FAMILIES STARTING AT AN OLDER AGE
The average age for a woman's first birth is similar across the UK, 28.8 (England and Wales), 12 28.7 (Scotland) 13 and 29.2 (Northern Ireland). 14 The average age of all women giving birth is also similar across the UK, 30.7 (England and Wales), 15 30.9 (Scotland) 16 and 31.1 in (Northern Ireland). 14 The average age of birth has been steadily increasing since the 1970s and the UK experience is similar to other high‐income countries. 17 Two child families remain the most common family size in England and Wales (37%). 18 Whether through choice or circumstance 20% of women do not have children by age 44 in the UK. 19 Overall, Europe has seen an increase in women who do not have children, but the rate in the UK is higher than many countries. 19
3. THE UK HAS A LOW RATE OF BREASTFEEDING
Defining the rate of breastfeeding is complex. It is straightforward to understand exclusive breastfeeding or no breastfeeding but there are many versions of combination feeding in between these two extremes. The category of ‘ever breastfed’ is used to allow comparisons globally. 20 This category is diverse as it will include babies who were breastfed for a few days as well as those breastfed for a year. Breastfeeding data is also influenced by how it is collected, some is routinely collected on every baby born, 21 whereas others are dependent on mothers responding to a survey and may not reflect the population as a whole. 22
In the UK women have low rates of breastfeeding, 81% of babies are ever‐breastfed. 20 Higher rates of ever breastfeeding occur in other high‐income countries such as Australia (92%) and Sweden (98%). 20 Although the rate of ever breastfeeding is similar in the USA (79%) and much lower in Ireland (55%). 20
In England, 72.7% of babies born at term had breastmilk as their first feed. 21 This is similar to the UK ever‐breastfed rate. 20 In Scotland 75% of mothers reported ever breastfeeding their babies. 22 Although, the true figure may be much lower as data collected by Health Visitors showed only 66% of Scottish babies were ever breastfed. 23 In Northern Ireland breastfeeding is attempted for 60% of babies while in hospital and only 46% are breastfed on discharge. 24 Across the UK breastfeeding is less common in younger mothers and in more deprived areas. 23 , 24 , 25 , 26
4. PREGNANCY AND BREAST‐CANCER RISK
Women in the UK born after 1960 have a 15% lifetime risk of developing breast cancer. 27 Postmenopausal women with one child have a 13% reduced risk of breast cancer compared to women without children. 28 Women with two and three children had a 19% and 29% reduced risk respectively. 28
However, the protective effects of pregnancy is dependent on the age a woman's first birth occurred. Young age of first full‐term pregnancy (<25) reduces the risk of breast cancer in postmenopausal women by 35% compared to nulliparous women. 29 When a first birth occurred at age 25–29, women had an 11% increased risk compared to women who gave birth at <20 years. 28 When a first birth occurs at over 30 years there is a 24% increase in breast‐cancer risk. 28 This is of concern as the age of first birth is rising in high‐income countries. In the UK 19.4% of first births are to women over the age of 29. 30
While this increased breast‐cancer risk for older mothers is concerning, what we are actually seeing is a reversal of the protective effects of pregnancy for young women. Women who have one child between the ages of 30 and 34 have the same risk nulliparous women. 31 , 32 Women who have one child over the age of 35 have a slightly increased risk. 31 The real increase in risk is seen in women who have multiple full‐term pregnancies aged over 35 years; there is a 57% increased risk compared to women with only one child. 31
Pregnancy is protective against breast cancer in the long‐term, but in the short‐term both the incidence of breast cancer and the aggressiveness of cancers that do occur increases. 33 , 34 The increased risk peaks at about 5 years after birth, but remains elevated for around 20 years. 34 Women without a family history of breast cancer experience increased risk with births over the age of 30. 35 Women with a family history of breast cancer experience increased risk regardless of their age giving birth. 35
Given the reduction in breast cancer risk when a woman's first pregnancy occurs at less than 30 years it would be prudent to include information on breast cancer risk with fertility education in schools. 36 However, there are complex social reasons why the age of first birth has been steadily increasing in high‐income countries. 19 Research on women who have turned to IVF due to infertility, in part as a result of delayed childbearing, found that 46% would not have changed their childbearing plans even with better fertility education. 37
5. BREASTFEEDING AND BREAST‐CANCER RISK
A large meta‐analysis of 47 studies from 30 countries examined the impact of breastfeeding on breast‐cancer risk. 38 The relative risk of breast cancer decreased by 4.3% for every 12 months of breastfeeding, which was in addition to the 7.0% decrease in risk observed for each birth. 38 The decreased risk of breast cancer associated with breastfeeding was the same in high and low income countries and did not vary with age, menopausal status, ethnic group or age at first birth. 38 The data truly indicate that breastfeeding universally decreases breast‐cancer risk. 38 In the context of a high‐income country such as the UK, a woman who has 2 children and breastfed for 12 months with each child will have reduced her risk of breast cancer by 8.6%.
Breastfeeding has been shown to not alter the protective effect of multiple pregnancies in women who had their first full‐term pregnancy before 25 years. 29 In contrast, women who had 3 or more children, with their first full‐term pregnancy after 25 years had a 106% increased breast‐cancer risk if they did not breast feed. 29 An estimated 4.7% of breast cancer cases in the UK are caused by not breastfeeding. 39 The percentages are higher in Scotland and Northern Ireland; 5.2% and 5.9% respectively 39 which corresponds with lower rates of breastfeeding described earlier. 23 , 24 In Australia, an estimated 1.7% of breast cancer cases are caused by lack of breastfeeding, this corresponds with the higher breastfeeding rate in Australia. 40
6. HOW DOES PREGNANCY AND BREASTFEEDING REDUCE THE RISK OF BREAST CANCER?
The protective effects of an early full‐term pregnancy and breastfeeding have been consistently seen in multiple countries and ethnic groups, suggesting that the protection results from biological changes in the breast rather than environmental or socioeconomic factors. 38 , 41
The human breast goes through remarkable changes during a woman's lifetime. During puberty increased levels of oestrogen and progesterone causes the breasts to enlarge. This is due to the development of the mammary glands and increased fatty tissue. 42 The breast contains 15–20 units called lobes, the lobes of the breast drain into lactiferous ducts which lead to the nipple. 43 Each lobe of the breast is made up of 20–40 lobules, and each lobule consists of 10–100 hollow cavities called alveoli. The alveoli are lined with epithelium which synthesises the protein and lipid components of breast milk. 43 Elevated hormone levels during pregnancy causes the ductal system to expands and the alveolar epithelium and the breast increases in size. 43 When breastfeeding stops there is a regression in the breast tissue but there is no substantial reduction of the mammary glands. 44 The lobules in the breast involute as a woman ages with reduction in number of alveoli. Over time there is a replacement of the mammary glands with fatty tissue. 44
6.1. Gene‐expression studies
Studies have sought to understand the difference in gene‐expression in breast tissue from women who have had children compared to those that have not. 45 , 46 , 47 , 48 Two studies examined normal‐breast tissue from healthy‐postmenopausal volunteers using breast‐core‐needle biopsies. 45 , 46 These studies both found 208 genes to be differentially expressed and 96 genes overlapped between the studies. Genes that were altered were primarily related to RNA processing and cellular differentiation. 45 , 46 A study which used microdissection to isolate normal‐breast tissue from breast‐cancer patients also found similar changes in gene expression to the core‐needle‐biopsy studies. 47 In contrast, a study which examined reduction‐mammoplasty samples did not find similar genes to the other studies. 48 This may be due to differences in breast tissue in women who have larger breasts or that this study included both pre and post‐menopausal women. 48 Only one gene was found across three or more of the gene‐expression studies, increased expression of TRAF3IP3. 45 , 46 , 48 TRAF3‐interacting protein 3 is involved in cell maturation, tissue development, and immune response. 49 Unfortunately, increased expression of TRAF3IP3 has been found in melanoma tumour samples and in the blood vessels of breast cancers. 49 , 50 Further research is needed to see if TRAF3IP3 plays a protective role in the parous breast.
6.2. Mammary‐epithelial stem cells
Terminal ductal lobuloalveolar units are regarded as the site of origin for the majority of human breast cancers and they contain mammary stem and progenitor cells. 51 Mammary‐stem cells are typically involved in the homeostasis of the organ but also in promoting the elongation and development of the mammary ducts and alveoli during pregnancy. 52 Studies in mice have found that an early pregnancy causes a persistent decrease in the number of functional mammary‐epithelial stem cells. 53 The maintenance or differentiation of stem cells and their progenitors relies on regulation through gene expression, including chromatin modification, transcription factors, microRNAs and regulation through alternative RNA splicing. 54 , 55 The gene‐expression studies in the parous breast found genes primarily related to RNA processing and cellular differentiation. 45 , 46 Suggesting that the reduction in breast‐cancer risk associated with pregnancy may be associated with an alteration in maintenance or differentiation of breast cancer stem cells.
7. SUBTYPES OF BREAST CANCER
Breast cancer is categorised into three major subtypes based on the presence or absence of oestrogen receptor or progesterone receptor known as hormone receptors (HR) and human epidermal growth factor 2 (HER2). 56 These three receptors are all growth factors, when overexpressed these stimulate the growth of cancer cells. 57 , 58 , 59
7.1. HR+
Hormone‐receptor positive and HER2 negative is the most common type of breast cancer representing 70% of cases. 56 When detected early and treated with endocrine therapy to block the hormone receptors, 60 99% of women survive 5 or more years. 56 If the cancer is metastatic, that is spread beyond the breast, survival is typically 4–5 years. 56
7.2. HER2+
HER2 positive breast cancers account for 15–20% of cases, about half of these cases are also hormone‐receptor positive. When detected early and treated with a combination of chemotherapy and HER2 inhibitors as well as endocrine therapy for those who are hormone‐receptor positive; 94% of women survive 5 or more years. 56 If the cancer is metastatic survival is typically 4–5 years. 56
7.3. Triple negative
Breast cancers that do not have hormone receptors or HER2. The cause of these cancers can be unknown but tumours from BRCA mutation carriers are typically within this subtype. 61 This subtype has the poorest prognosis, when detected early and treated with chemotherapy only 85% of women survive 5 or more years. If the cancer is metastatic, survival is typically only 10–13 months. 56
8. PREGNANCY AND SUBTYPES OF BREAST CANCER
8.1. HR+
Young age of first full‐term pregnancy (<25) was found to reduce the risk of HR+ breast cancer by 18–40% compared to women without children. 29 , 62 One or more full‐term pregnancy was found to reduce the risk of HR+ breast cancer by 29–35% compared to women without children. 63 , 64
8.2. HER2+
The literature on the risk of HER2+ breast cancer and pregnancy does not have a clear consensus. Some studies show an increased risk with one or more birth, 65 , 66 some no change 64 and others a decreased risk. 63
8.3. Triple negative
One or more full‐term pregnancy was found to reduce the risk of triple‐negative breast cancer by 30% in women aged 20–44 compared to women without children. 64
8.4. BRCA1/2 carriers
Pregnancy is associated with a reduced risk of breast cancer in BRCA1/2 carriers, the greater number of pregnancies the larger the reduction in risk was observed. 34 , 67 A meta‐analysis has shown that a BRCA1/2 carrier needs to have three or more live births to reduce her breast‐cancer risk. 68 Very‐young age at first full‐term pregnancy (<21 years) was found to decrease the risk of breast cancer by 9% for women with a BRCA1 mutation and by 17% for women with a BRCA2 mutation. 69
9. BREASTFEEDING AND SUBTYPES OF BREAST CANCER
9.1. HR+
A 2015 meta‐analysis found no reduction in the risk for hormone‐receptor positive breast cancer associated with breastfeeding. 11 There are a lot of studies on the topic and those that find a reduction in risk tend to be case–control studies where women with cancer are compared to age‐matched controls. 63 In contrast, studies which follow a cohort of women over time in have not found a reduction in risk. 65
9.2. HER2+
The studies that found an increased risk of HER2+ breast cancer with pregnancy, had a lower risk in women who breastfed. 65 , 66 The studies that found either no change or a decrease in risk associated with pregnancy also found no change with breastfeeding. 63 , 64
9.3. Triple negative
A 2015 meta‐analysis found a 20% reduction in the risk for triple‐negative breast cancer associated with breastfeeding. 11 This reduction in risk was seen in both case–control and cohort studies. 11 Another more recent study found a 191% increase in the risk of triple‐negative breast cancer in women who had children but did not breastfeed. 63
9.4. BRCA mutations
Women with BRCA1 mutations who breastfed for more than one year were found to have a 22–50% reduced risk of breast cancer than those who never breastfed. 68 , 70 This large reduction in risk is notable as comes in a population that is at especially high risk of breast cancer. Women with BRCA1 mutations have a 65% risk of developing breast cancer by age 70. 71 In contrast, there is no decreased risk associated with breastfeeding for women with BRCA2 mutations. 70
Women with a family history of breast cancer should particularly be supported to breastfeed as a way of reducing their cancer risk. Many women are unaware of having a BRCA mutation and their increased cancer risk. 72 Women with a carrier probability of less than 10% are currently ineligible to access free genetic testing for BRCA in the UK. 73 , 74 This is however, likely to change in the near future as the cost of genetic testing comes down. 72
10. WHY DO WOMEN IN THE UK CHOOSE NOT TO BREASTFEED OR TO STOP BREASTFEEDING?
Breastfeeding is a highly‐emotive subject because so many women have not breastfed, or have experienced the pain of trying very hard to breastfeed and not succeeding. 75 There are many reasons why women in high‐income countries choose not to breastfeed or to stop breastfeeding sooner than they intended to do so. 76 , 77
10.1. Insufficient milk
Public Health England recently studied mothers perceived barriers to breastfeeding. 78 Mothers primary concern was worrying that the baby was getting enough milk or the right nutrients. 78 Perceived insufficient milk supply is one of the top reasons that women stop breastfeeding 79 although true‐milk insufficiency effects only around 10% of mothers. 80 Many of the problems women experience with low‐milk supply has to do with how often milk is removed from the breast. 77 If an infant is fed frequently and responsively this leads to a greater milk supply. 77
10.2. Nipple pain and difficulties with latch
Problems can be caused by common conditions such as tongue‐tie in the infant 81 and inverted nipples in the mother. 80 Pain while breastfeeding can lead to women weaning their baby prematurely often in the first week after birth. 82 , 83
10.3. Professional support and public health policy
First‐time mothers, have little experience of seeing breastfeeding in their community and need additional support in positioning and attachment of the baby. 77 Women benefit from the support of both professional and peer‐support breastfeeding networks 76 and those who experience problems but did not get professional help were more likely to stop breastfeeding. 79 This has been challenging in recent years due to the COVID‐19 pandemic. 84
The “Ten Steps to Healthy Breastfeeding” are the basis of the WHO/UNICEF Baby‐Friendly Hospital Initiative 85 (Box 1). However, there is little consensus on the most effective format to deliver prenatal breastfeeding education. 86 Sweden has had 97% of its hospitals designated as Baby‐Friendly since 2000. 87 In contrast, Ireland and the USA only have 47% and 12% of hospitals designated as Baby‐Friendly. 87 The UK only has 43% of maternity services and 67% of health‐visiting services with full Baby‐Friendly accreditation. 88 However, 95% of maternity services and 91% of health‐visiting services in the UK are working towards Baby‐Friendly accreditation. 88
BOX 1. Ten Steps to Successful Breastfeeding.
Every facility providing maternity services and care for new‐born infants should:
1. Have a written breastfeeding policy that is routinely communicated to all health care staff.
2. Train all health care staff in skills necessary to implement this policy.
3. Inform all pregnant women about the benefits and management of breastfeeding.
4. Help mothers initiate breastfeeding within a half‐hour of birth.
5. Show mothers how to breastfeed, and how to maintain lactation even if they should be separated from their infants.
6. Give new‐born infants no food or drink other than breastmilk, unless medically indicated.
7. Practice rooming‐in ‐ allow mothers and infants to remain together −24 hours a day.
8. Encourage breastfeeding on demand.
9. Give no artificial teats or pacifiers (also called dummies or soothers) to breastfeeding infants.
10. Foster the establishment of breastfeeding support groups and refer mothers to them on discharge from the hospital or clinic.
10.4. Family and friends attitudes to breastfeeding
Women do not breastfeed in isolation and rely on the advice and support of their family. A woman's partner is the most helpful or influential on feeding practices. 84 , 89 Mothers in the UK are more likely to breastfeed if they themselves were breastfed and most of their friends breastfeed. 79 The advice women receive from their mother and mother‐in‐law is also very important. 77 , 90 However, this advice can often reflect cultural beliefs that aren't necessarily supportive of breastfeeding and may include outdated guidelines. 90 The breastfeeding rates in the UK were even lower 30–40 years ago, 51% of women initiated breastfeeding in 1975 and 62% in 1990. 79 As such the UK has a generation of grandmothers with less experience with successful breastfeeding than their daughters.
Sweden has historically high rates of breastfeeding initiation, which was 97% in 1990. 87 As such Sweden is operating from a position of strength, the population has high levels of experience with breastfeeding. Conversely, The USA and Ireland had low rates of breastfeeding initiation in the 1990s (57% and 31.7%) 87 and like the UK have had to build up experience in the population.
10.5. Public attitudes and legislation
Despite breastfeeding being protected by UK law 91 women in the UK reported embarrassment over breastfeeding in public. 79 Similar experiences have been reported in other high‐income countries such as Australia. 92
10.6. Breastfeeding and the workplace
The longer the duration of a mother's maternity leave the longer the duration of breastfeeding. 93 This is also associated with socioeconomic status, as women in higher‐income jobs may have additional maternity leave beyond the minimum statutory requirement or be more able to afford to take unpaid leave.
Breastfeeding in the workplace is not adequately protected in UK law. The law requires an employer to provide a space to rest including the ability to lie down. 94 However, the law does not require the employer to grant paid breaks from work to express milk or breastfeed or provide facilities for the storage of expressed milk. 94 This lack of legislation in the UK is a barrier to breastfeeding particularly for women who work in complex environments such as the armed forces. 95 In contrast, the legislation in 121 countries provide for paid or unpaid breaks for lactating mothers, including the United States and Ireland. 96 Using a lactation room in the workplace has been associated with longer duration of breastfeeding in working mothers. 97
10.7. Promotion of formula milk
Formula milk is an essential product for children with complex medical needs and for those women who cannot breastfeed. 98 However, decisions on the use of infant formula should be based on evidence and not advertising. 98 The World Health Organisation launched an International Code of Marketing Breastmilk substitutes in 1981, it explicitly bans advertising and promotion to the general public. 99 70% of countries have adopted legal measures to implement the code. 100 It is illegal in the UK to promote formula‐milk aimed at infants less than 6 months old, but the advertising of follow‐on milks for infants over 6 months is permitted. 101 The UK is similar to most of Europe in that it has very few parts of the WHO Code adopted in law. 100 Countries with similar laws to the UK that were enacted at a similar time have very divergent breastfeeding rates Sweden (98%) vs Ireland (55%). 20 , 100 Countries with no laws around the advertising of formula also have very divergent rates of breastfeeding Australia (92%) vs USA (79%). 20 , 100 Clearly, laws about the advertising of formula cannot explain the diversity of breastfeeding rates in high‐income countries. However, countries where the rates of breastfeeding are lower like the UK and Ireland are more likely to benefit from stricter legislation.
11. CONCLUSION
Breastfeeding reduces the risk of breast cancer by 4.3% for every 12 months of breastfeeding, which is in addition to the 7.0% decrease in risk observed for each birth. Breastfeeding has been shown to primarily reduce the risk of Triple‐Negative Breast Cancer (20%) as well as in carriers of BRCA1 mutations (22–50%). Women with a family history of breast cancer should particularly be supported to breastfeed as a way of reducing their cancer risk.
The molecular mechanisms of reduced breast‐cancer risk as a result of pregnancy appear to be related to RNA processing and cellular differentiation and may be associated with an alteration in maintenance or differentiation of breast cancer stem cells.
The UK has a low rate of breastfeeding in part due to a lack of experience in the population. An estimated 4.7% of breast cancer cases in the UK are caused by not breastfeeding. Expansion of the Baby‐Friendly Hospital Initiative, stricter laws on the advertising of formula milk and legislation to support nursing mothers in the workplace have the potential to increase breastfeeding rates in the UK.
AUTHOR CONTRIBUTIONS
Britta Stordal: Funding acquisition (lead); investigation (lead); methodology (lead); writing – original draft (lead); writing – review and editing (lead).
CONFLICT OF INTEREST
The author has no financial or non‐financial interests related to the work submitted for publication. The author states that there is no conflict of interest.
ETHICS APPROVAL
This study was approved by the Natural Science Research Ethics Committee at Middlesex University. This study did not involve human participants or patient material, so no written informed consent was required.
Supporting information
Appendix S1
ACKNOWLEDGMENTS
This work was commissioned by the charity Breast Cancer UK.
Stordal B. Breastfeeding reduces the risk of breast cancer: A call for action in high‐income countries with low rates of breastfeeding. Cancer Med. 2023;12:4616‐4625. doi: 10.1002/cam4.5288
DATA AVAILABILITY STATEMENT
N/A
REFERENCES
- 1. Sankar MJ, Sinha B, Chowdhury R, et al. Optimal breastfeeding practices and infant and child mortality: a systematic review and meta‐analysis. Acta Paediatr Oslo nor. 1992;2015(104):3‐13. [DOI] [PubMed] [Google Scholar]
- 2. Horta BL, Victora CG. Short‐term effects of breastfeeding: a systematic review on the benefits of breastfeeding on diarrhoea and pneumonia mortality. World Health Organisation; 2013. [Google Scholar]
- 3. Bowatte G, Tham R, Allen K, et al. Breastfeeding and childhood acute otitis media: a systematic review and meta‐analysis. Acta Paediatr. 2015;104:85‐95. [DOI] [PubMed] [Google Scholar]
- 4. Lodge CJ, Tan DJ, Lau MXZ, et al. Breastfeeding and asthma and allergies: a systematic review and meta‐analysis. Acta Paediatr Oslo nor. 1992;2015(104):38‐53. [DOI] [PubMed] [Google Scholar]
- 5. Horta BL, Loret de Mola C, Victora CG. Long‐term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure and type 2 diabetes: a systematic review and meta‐analysis. Acta Paediatr. 2015;104:30‐37. [DOI] [PubMed] [Google Scholar]
- 6. Nguyen B, Gale J, Nassar N, et al. Breastfeeding and cardiovascular disease hospitalization and mortality in parous women: evidence from a large Australian cohort study. J Am Heart Assoc. 2019;8:e011056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Rajaei S, Rigdon J, Crowe S, Tremmel J, Tsai S, Assimes TL. Breastfeeding duration and the risk of coronary artery disease. J Womens Health Larchmt. 2019;28:30‐36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Aune D, Norat T, Romundstad P, et al. Breastfeeding and the maternal risk of type 2 diabetes: a systematic review and dose‐response meta‐analysis of cohort studies. Nutr Metab Cardiovasc. 2014;24:107‐115. [DOI] [PubMed] [Google Scholar]
- 9. Jager S, Jacobs S, Kroger J, et al. Breast‐feeding and maternal risk of type 2 diabetes: a prospective study and meta‐analysis. Diabetologia. 2014;57:1355‐1365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Chowdhury R, Sinha B, Sankar MJ, et al. Breastfeeding and maternal health outcomes: a systematic review and meta‐analysis. Acta Paediatr. 2015;104:96‐113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Islami F, Liu Y, Jemal A, et al. Breastfeeding and breast cancer risk by receptor status‐‐a systematic review and meta‐analysis. Ann Oncol. 2015;26:2398‐2407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Birth characteristics in England and Wales: 2017 . 2018. Office for National Statistics. Accessed 31 March 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/livebirths/bulletins/birthcharacteristicsinenglandandwales/2017
- 13. Births in Scottish Hospitals ‐ Year ending 31 March . 2022. Public Health Scotland, (30 November 2021, Accessed 1 April 2022). https://publichealthscotland.scot/publications/births‐in‐scottish‐hospitals/births‐in‐scottish‐hospitals‐year‐ending‐31‐march‐2021/
- 14. Birth Statistics . 2022. Northern Ireland Statistics and Research Agency. Accessed 31 March 2022. https://www.nisra.gov.uk/publications/birth‐statistics
- 15. Births in England and Wales: 2020 . 2021. Office for National Statistics. Accessed 31 March 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/livebirths/bulletins/birthsummarytablesenglandandwales/latest
- 16. Vital Events Reference Tables 2020 . National Records of Scotland. 2021, Accessed 31 March 2022. https://www.nrscotland.gov.uk/files//statistics/vital‐events‐ref‐tables/2020/vital‐events‐ref‐tables‐20‐publication.pdf
- 17. SF2.3 age of mothers at childbirth and age‐specific fertility. OECD; 2021. [Google Scholar]
- 18. Sharfman A. Childbearing for women born in different years, England and Wales ‐ Office for National Statistics. Office for National Statistics. 2022, Accessed 12 August. 2022https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/conceptionandfertilityrates/bulletins/childbearingforwomenbornindifferentyearsenglandandwales/2020
- 19. Miettinen A, Rotkirch A, Szalma I, et al. Increasing childlessness in Europe: time trends and country differences . 2015.
- 20. Victora CG, Bahl R, Barros AJD, et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet Lond Engl. 2016;387:475‐490. [DOI] [PubMed] [Google Scholar]
- 21. NHS Maternity Statistics, England ‐ 2020–21 . Community and Mental Health Team, NHS Digital, 25 November 2021. https://digital.nhs.uk/data‐and‐information/publications/statistical/nhs‐maternity‐statistics/2020‐21
- 22. Scottish Maternal and Infant Nutrition Survey 2017 . Healthcare Quality and Improvement Directorate Scottish Government, 2018. Accessed 1 April 2022. https://www.gov.scot/publications/scottish‐maternal‐infant‐nutrition‐survey‐2017/documents/
- 23. Infant Feeding Statistics Scotland . Public Health Scotland, 2021. Accessed 1 April 2022. https://publichealthscotland.scot/publications/infant‐feeding‐statistics/infant‐feeding‐statistics‐financial‐year‐2020‐to‐2021/
- 24. Health Intelligence Briefing: Breastfeeding in Northern Ireland . Public Health Agency ‐ Health and Social Care Northern Ireland, 2018, Accessed 1 April 2022. https://www.publichealth.hscni.net/sites/default/files/2018‐12/Breastfeeding%20in%20Northern%20Ireland,%20September%202018.pdf
- 25. Oakley LL, Renfrew MJ, Kurinczuk JJ, Quigley MA. Factors associated with breastfeeding in England: an analysis by primary care trust. BMJ Open. 2013;3:e002765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Maternity and birth statistics: 2020 . 2021. Welsh Government. Accessed 12 April 2022. https://gov.wales/sites/default/files/pdf‐versions/2021/5/4/1620894624/maternity‐and‐birth‐statistics‐2020.pdf
- 27. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer incidence and mortality projections in the UK until 2035. Br J Cancer. 2016;115:1147‐1155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Reeves GK, Pirie K, Green J, Bull D, Beral V, For the Million Women Study Collaborators . Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer. Int J Cancer. 2012;131:930‐937. [DOI] [PubMed] [Google Scholar]
- 29. Lord SJ, Bernstein L, Johnson KA, et al. Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case‐control study. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2008;17:1723‐1730. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Lee A, Mavaddat N, Wilcox AN, et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med off J Am Coll Med Genet. 2019;21:1708‐1718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. MacMahon B, Cole P, Lin TM, et al. Age at first birth and breast cancer risk. Bull World Health Organ. 1970;43:209‐221. [PMC free article] [PubMed] [Google Scholar]
- 32. Meier‐Abt F, Bentires‐Alj M. How pregnancy at early age protects against breast cancer. Trends Mol Med. 2014;20:143‐153. [DOI] [PubMed] [Google Scholar]
- 33. Asztalos S, Gann PH, Hayes MK, et al. Gene expression patterns in the human breast after pregnancy. Cancer Prev Res Phila pa. 2010;3:301‐311. [DOI] [PubMed] [Google Scholar]
- 34. Nichols HB, Schoemaker MJ, Cai J, et al. Breast cancer risk after recent childbirth: a pooled analysis of 15 prospective studies. Ann Intern Med. 2019;170:22‐30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Albrektsen G, Heuch I, Hansen S, Kvåle G. Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer. 2005;92:167‐175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Department for education. Relationships education, relationships and sex education (RSE) and health education. Department for Education; 2019. [Google Scholar]
- 37. Mac Dougall K, Beyene Y, Nachtigall R. Age shock: misperceptions of the impact of age on fertility before and after IVF in women who conceived after age 40. Hum Reprod. 2013;28(2):350‐356. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Collaborative Group on Hormonal Factors in Breast Cancer . Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet Lond Engl. 2002;360:187‐195. [DOI] [PubMed] [Google Scholar]
- 39. Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer. 2018;118:1130‐1141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Jordan SJ, Wilson LF, Nagle CM, et al. Cancers in Australia in 2010 attributable to total breastfeeding durations of 12 months or less by parous women. Aust N Z J Public Health. 2015;39:418‐421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Blakely CM, Stoddard AJ, Belka GK, et al. Hormone‐induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a Core gene expression signature induced by pregnancy. Cancer Res. 2006;66:6421‐6431. [DOI] [PubMed] [Google Scholar]
- 42. Pandya S, Moore RG. Breast development and anatomy. Clin Obstet Gynecol. 2011;54:91‐95. [DOI] [PubMed] [Google Scholar]
- 43. Alex A, Bhandary E, McGuire KP. Anatomy and physiology of the breast during pregnancy and lactation. Adv Exp Med Biol. 2020;1252:3‐7. [DOI] [PubMed] [Google Scholar]
- 44. Milanese TR, Hartmann LC, Sellers TA, et al. Age‐related lobular involution and risk of breast cancer. J Natl Cancer Inst. 2006;98:1600‐1607. [DOI] [PubMed] [Google Scholar]
- 45. Peri S, de Cicco RL, Santucci‐Pereira J, et al. Defining the genomic signature of the parous breast. BMC Med Genomics. 2012;5:46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Belitskaya‐Lévy I, Zeleniuch‐Jacquotte A, Russo J, et al. Characterization of a genomic signature of pregnancy identified in the breast. Cancer Prev Res Phila pa. 2011;4:1457‐1464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Russo J, Balogh GA, Russo IH. Full‐term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2008;17:51‐66. [DOI] [PubMed] [Google Scholar]
- 48. Rotunno M, Sun X, Figueroa J, et al. Parity‐related molecular signatures and breast cancer subtypes by estrogen receptor status. Breast Cancer Res BCR. 2014;16:R74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Nasarre P, Bonilla IV, Metcalf JS, Hilliard EG, Klauber‐DeMore N. TRAF3‐interacting protein 3, a new oncotarget, promotes tumor growth in melanoma. Melanoma Res. 2018;28:185‐194. [DOI] [PubMed] [Google Scholar]
- 50. Bhati R, Patterson C, Livasy CA, et al. Molecular characterization of human breast tumor vascular cells. Am J Pathol. 2008;172:1381‐1390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Tharmapalan P, Mahendralingam M, Berman HK, Khokha R. Mammary stem cells and progenitors: targeting the roots of breast cancer for prevention. EMBO J. 2019;38:e100852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Taurin S, Alkhalifa H. Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses. Neoplasia N Y N. 2020;22:663‐678. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Siwko SK, Dong J, Lewis MT, Liu H, Hilsenbeck SG, Li Y. Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells—implications for pregnancy‐induced protection against breast cancer. Stem Cells Dayt Ohio. 2008;26:3205‐3209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Ebrahimie E, Rahimirad S, Tahsili M, Mohammadi‐Dehcheshmeh M. Alternative RNA splicing in stem cells and cancer stem cells: importance of transcript‐based expression analysis. World J Stem Cells. 2021;13:1394‐1416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Pritsker M, Doniger TT, Kramer LC, Westcot SE, Lemischka IR. Diversification of stem cell molecular repertoire by alternative splicing. Proc Natl Acad Sci U S A. 2005;102:14290‐14295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Waks AG, Winer EP. Breast cancer treatment: a review. Jama J Am Med Assoc. 2019;321:288‐300. [DOI] [PubMed] [Google Scholar]
- 57. Trabert B, Sherman ME, Kannan N, Stanczyk FZ. Progesterone and breast cancer. Endocr Rev. 2019;41:320‐344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Di Fiore PP, Pierce JH, Kraus MH, et al. erbB‐2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science. 1987;237:178‐182. [DOI] [PubMed] [Google Scholar]
- 59. Saha Roy S, Vadlamudi RK. Role of estrogen receptor signaling in breast cancer metastasis. Int J Breast Cancer. 2012;2012:654698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Chien T‐J. A review of the endocrine resistance in hormone‐positive breast cancer. Am J Cancer Res. 2021;11:3813‐3831. [PMC free article] [PubMed] [Google Scholar]
- 61. Chen H, Wu J, Zhang Z, et al. Association between BRCA status and triple‐negative breast cancer: a meta‐analysis. Front Pharmacol. 2018;9:909. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE. Risk factors for breast cancer according to estrogen and progesterone receptor status. JNCI J Natl Cancer Inst. 2004;96:218‐228. [DOI] [PubMed] [Google Scholar]
- 63. Holm J, Eriksson L, Ploner A, et al. Assessment of breast cancer risk factors reveals subtype heterogeneity. Cancer Res. 2017;77:3708‐3717. [DOI] [PubMed] [Google Scholar]
- 64. Li CI, Beaber EF, Tang M‐TC, Porter PL, Daling JR, Malone KE. Reproductive factors and risk of estrogen receptor positive, triple‐negative, and HER2‐neu overexpressing breast cancer among women 20‐44 years of age. Breast Cancer Res Treat. 2013;137:579‐587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Fortner RT, Sisti J, Chai B, et al. Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses' health studies. Breast Cancer Res BCR. 2019;21:40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Chen L, Li CI, Tang M‐TC, et al. Reproductive factors and risk of luminal, HER2‐overexpressing, and triple‐negative breast cancer among multiethnic women. Cancer epidemiol biomark Prev Publ am Assoc cancer res cosponsored am soc Prev . Oncologia. 2016;25:1297‐1304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Toss A, Grandi G, Cagnacci A, et al. The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation. Oncotarget. 2017;8:9144‐9154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Friebel TM, Domchek SM, Rebbeck TR. Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta‐analysis. JNCI J Natl Cancer Inst. 2014;106:dju091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Evans DG, Howell A, Ward D, Lalloo F, Jones JL, Eccles DM. Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer. J Med Genet. 2011;48:520‐522. [DOI] [PubMed] [Google Scholar]
- 70. Jernström H, Lubinski J, Lynch HT, et al. Breast‐feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2004;96:1094‐1098. [DOI] [PubMed] [Google Scholar]
- 71. Antoniou A, Pharoah PDP, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72:1117‐1130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. NICE . Guideline Scope ‐ Ovarian cancer: identifying and managing familial and genetic risk . 2022. Accessed 4 July 2022. https://www.nice.org.uk/guidance/gid‐ng10225/documents/final‐scope
- 73. Carver T, Hartley S, Lee A, et al. CanRisk tool—a web Interface for the prediction of breast and ovarian cancer risk and the likelihood of carrying genetic pathogenic variants. Cancer Epidemiol Biomarkers Prev. 2021;30:469‐473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. NICE . Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer | guidance |NICE. NICE, 2019. Accessed 11 August 2022. https://www.nice.org.uk/Guidance/CG164 [PubMed] [Google Scholar]
- 75. Removing the Barriers to Breastfeeding: A Call to Action. UNICEF UK. 2017, Accessed 31 March 2022. https://www.unicef.org.uk/babyfriendly/wp‐content/uploads/sites/2/2017/07/Barriers‐to‐Breastfeeding‐Briefing‐The‐Baby‐Friendly‐Initiative.pdf [Google Scholar]
- 76. Fox R, McMullen S, Newburn M. UK women's experiences of breastfeeding and additional breastfeeding support: a qualitative study of baby Café services. BMC Pregnancy Childbirth. 2015;15:147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Brown A. Why are breastfeeding rates in the UK so low? A Guide to Supporting Breastfeeding for the Medical Profession. Routledge; 2019. [Google Scholar]
- 78. Perceived barriers to breastfeeding . Public Health England, 2017, Accessed 31 March 2022. https://www.gov.uk/government/news/new‐survey‐of‐mums‐reveals‐perceived‐barriers‐to‐breastfeeding
- 79. McAndrew F, Thompson J, Fellows L, et al. Infant Feeding Survey 2010. The Information Centre for Health and Social Care, 2010, Accessed 11 April 2022. https://webarchive.nationalarchives.gov.uk/ukgwa/20171011022214tf_/http://content.digital.nhs.uk/catalogue/PUB08694/Infant‐Feeding‐Survey‐2010‐Consolidated‐Report.pdf
- 80. Neifert M, DeMarzo S, Seacat J, Young D, Leff M, Orleans M. The influence of breast surgery, breast appearance, and pregnancy‐induced breast changes on lactation sufficiency as measured by infant weight gain. Birth Berkeley Calif. 1990;17:31‐38. [DOI] [PubMed] [Google Scholar]
- 81. Edmunds J, Miles SC, Fulbrook P. Tongue‐tie and breastfeeding: a review of the literature. Breastfeed Rev Prof Publ Nurs Mothers Assoc Aust. 2011;19:19‐26. [PubMed] [Google Scholar]
- 82. McClellan HL, Hepworth AR, Garbin CP, et al. Nipple pain during breastfeeding with or without visible trauma. J Hum Lact off J Int Lact Consult Assoc. 2012;28:511‐521. [DOI] [PubMed] [Google Scholar]
- 83. Schwartz K, D'Arcy HJS, Gillespie B, Bobo J, Longeway M, Foxman B. Factors associated with weaning in the first 3 months postpartum. J Fam Pract. 2002;51:439‐444. [PubMed] [Google Scholar]
- 84. Vazquez‐Vazquez A, Dib S, Rougeaux E, Wells JC, Fewtrell MS. The impact of the Covid‐19 lockdown on the experiences and feeding practices of new mothers in the UK: preliminary data from the COVID‐19 new mum study. Appetite. 2021;156:104985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. World Health Organization . Division of Child Health and Development. Evidence for the ten steps to successful breastfeeding. WHO/CHD/98.9, World Health Organization. 1998, Accessed 12 April 2022. https://apps.who.int/iris/handle/10665/43633 [Google Scholar]
- 86. Wouk K, Tully KP, Labbok MH. Systematic review of evidence for baby‐friendly hospital initiative step 3. J Hum Lact off J Int Lact Consult Assoc. 2017;33:50‐82. [DOI] [PubMed] [Google Scholar]
- 87. Lubold AM. Historical‐qualitative analysis of breastfeeding trends in three OECD countries. Int Breastfeed J. 2019;14:36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Accreditation Statistics and Awards Table: The Baby Friendly Initiative. UNICEF UK , 2022, Accessed 12 April 2022. https://www.unicef.org.uk/babyfriendly/about/accreditation‐statistics‐and‐awards‐table‐2/
- 89. Rempel LA, Rempel JK, Moore KCJ. Relationships between types of father breastfeeding support and breastfeeding outcomes. Epub Ahead of Print 2017. e12337. 10.1111/mcn.12337 [DOI] [PMC free article] [PubMed]
- 90. Grassley J, Eschiti V. Grandmother breastfeeding support: what do mothers need and want? Birth Berkeley Calif. 2008;35:329‐335. [DOI] [PubMed] [Google Scholar]
- 91. Equality Act 2010 . UK Public General Acts, 2010. Accessed 11 April 2022. https://www.legislation.gov.uk/ukpga/2010/15/contents
- 92. Sheehan A, Gribble K, Schmied V. It's okay to breastfeed in public but…. Int Breastfeed J. 2019;14:24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93. Steurer LM. Maternity leave length and workplace Policies' impact on the sustainment of breastfeeding: global perspectives. Public Health Nurs Boston Mass. 2017;34:286‐294. [DOI] [PubMed] [Google Scholar]
- 94. ACAS . Accommodating breastfeeding employees in the workplace. Advisory, Conciliation and Arbitration Service, 2014. Accessed 11 August 2022. https://www.acas.org.uk/sites/default/files/2021‐03/acas‐guide‐on‐accommodating‐breastfeeding‐in‐the‐workplace.pdf
- 95. Taylor H. Enablers and barriers to workplace breastfeeding in the armed forces: a systematic review. BMJ mMil Health. 2021;bmjmilitary‐2020‐001724. [DOI] [PubMed] [Google Scholar]
- 96. Laura Addati NC and KG . Maternity and paternity at work: Law and practice across the world , 2014, Accessed 11 August 2022. http://www.ilo.org/global/publications/ilo‐bookstore/order‐online/books/WCMS_242615/lang‐‐en/index.htm
- 97. Ibarra‐Ortega A, Vásquez‐Garibay EM, Larrosa‐Haro A, Castro‐Albarrán J, Vizmanos‐Lamotte B. Using a lactation room at the workplace is associated with longer breastfeeding duration in working mothers. Nutr Hosp. 2020;37:918‐925. [DOI] [PubMed] [Google Scholar]
- 98. Godlee F, Cook S, Coombes R, et al. Calling time on formula milk adverts. BMJ. 2019;364:1200. [DOI] [PubMed] [Google Scholar]
- 99. International code of Marketing of Breast‐Milk Substitutes. World Health Organisation, 1981, Accessed 11 April 2022. https://www.who.int/publications/i/item/9241541601 [Google Scholar]
- 100. Marketing of breast milk substitutes: national implementation of the international code, status report 2020 , 2020, Accessed 11 April 2022. https://www.who.int/publications/i/item/9789240006010
- 101. The Infant Formula and Follow‐on Formula (England) Regulations 2007 . UK Statutory Instruments, 2007, Accessed 11 April 2022. https://www.legislation.gov.uk/uksi/2007/3521/regulation/23/made
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Appendix S1
Data Availability Statement
N/A